Results of a phase II multicenter study of minimally invasive esophagectomy (Eastern Cooperative Oncology Group Study E2202).

@article{Luketich2009ResultsOA,
  title={Results of a phase II multicenter study of minimally invasive esophagectomy (Eastern Cooperative Oncology Group Study E2202).},
  author={J. Luketich and A. Pennathur and P. Catalano and S. Swanson and A. D. de Hoyos and M. Maddaus and N. Nguyen and A. Benson and H. Fernando},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 15_suppl},
  pages={4516}
}
  • J. Luketich, A. Pennathur, +6 authors H. Fernando
  • Published 2009
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 4516 Background: The incidence of esophagogastric adenocarcinoma (EAC) is increasing at an alarming rate in the United States. Definitive treatment may require a combination of surgery (esophagectomy), chemotherapy and radiation. Operative mortality rates after esophagectomy have been reported as high as 8-23% (NEJM 2003). Minimally invasive esophagectomy (MIE) may decrease morbidity and mortality. Previous single institution studies have demonstrated successful outcomes with MIE. The primary… CONTINUE READING
    A Critical Review of Minimally Invasive Esophagectomy
    • 20